Dr. Mahajan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
9500 Euclid Ave
U-10
Cleveland, OH 44195- Is this information wrong?
Summary
- Dr. Kedar Mahajan is a neurologist in Cleveland, OH and is affiliated with multiple hospitals in the area, including Cleveland Clinic and Hillcrest Hospital. He received his medical degree from Rutgers New Jersey Medical School and has been in practice 4 years. He specializes in neuroimmunology/multiple sclerosis and is experienced in multiple sclerosis, demyelinating diseases, neuroimmunology (multiple sclerosis), and tor serine-threonine kinases.
Education & Training
- Cleveland Clinic FoundationFellowship, Neuroimmunology & Multiple Sclerosis, 2016 - 2018
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Neurology, 2013 - 2016
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 2012 - 2016
- Rutgers-Graduate School of Biomedical SciencesPhD Neuroscience, 2007 - 2012
- Rutgers New Jersey Medical SchoolClass of 2012
- Rowan UniversityBS, Biochemistry, Magna Cum Laude, 2001 - 2005
Certifications & Licensure
- OH State Medical License 2016 - 2024
- PA State Medical License 2012 - 2016
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Recipient of Young Investigator Education Enhancement Award American Neurochemistry Society, 2009
- Awarded a $60,000 Pre-Doctoral Fellowship UMDNJ - Graduate School of Bio medical Sciences (Newark, NJ), 2008, 2010
- Medallion Awardfor Excellence in Chemistry and Biochemistry Rowan University,Glassboro, NJ, 2005
Publications & Presentations
PubMed
- 1 citationsEffect of ibudilast on thalamic magnetization transfer ratio and volume in progressive multiple sclerosis.Kunio Nakamura, Yufan Zheng, Kedar R Mahajan, Jeffrey A Cohen, Robert J Fox, Daniel Ontaneda> ;Multiple Sclerosis. 2023 Sep 1
- 14 citationsNeurodegeneration in multiple sclerosis.Gabrielle M Mey, Kedar R Mahajan, Tara M DeSilva> ;Wires Mechanisms of Disease. 2023 Jan 1
- Correction to: Visual imaging as a predictor of neurodegeneration in experimental autoimmune demyelination and multiple sclerosis.Gabrielle M Mey, Kirsten S Evonuk, McKenzie K Chappell, Laura M Wolfe, Rupesh Singh, Julia C Batoki, Neal S Peachey, Bela Anand-Apte, Robert Bermel, Daniel Ontaneda, K...> ;Acta Neuropathologica Communications. 2022 Jul 15
- Join now to see all
Journal Articles
- What Is “Sleep-Disordered Breathing” for Patients With Neuromuscular Weakness?Bach, JR, Mahajan, K, Am J Phys Med Rehabil. 2007. 1744-1745
Books/Book Chapters
Abstracts/Posters
- IGF-1/PI3K/Akt Mediated Oligodendrocyte Development.Kedar Mahajan, William Tyler and Teresa L. Wood, American Society for Neurochemistry Conference., Sante Fe, NM
- IGF-1 Stimulated Akt Phosphorylation and OPC Survival Requires Cholesterol Enriched Membranes.Kedar Mahajan et al, American Society for Neurochemistry Conference, Charleston, SC
- Role of Cholesterol Enriched Membrane Microdomains in IGF-1 Mediated Oligodendrocyte Progenitor Survival.Kedar Mahajan et al, Society for Neuroscience Symposium: Cultivating Neuroscience, Garden State (CNgS). Newark, NJ
- Join now to see all
Press Mentions
- Assessing Deep Gray Matter Atrophy as a Predictor of Clinical Disability in MSMay 7th, 2019
Hospital Affiliations
- Cleveland ClinicCleveland, Ohio
- Cleveland Clinic Hillcrest HospitalCleveland, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: